China3D printingNet, April 30, biotechnology companies are discovering new ways to develop drugs in a variety of therapeutic areas. To demonstrate their commitment to drug discovery and move away from traditional laboratory animal models, many companies are adopting new technologies that may prove more relevant to human physiology. In recent years, there have been many reports that have promoted changes in the industry. For example, Gail Van Norman, a professor in the Department of Anesthesiology and Pain Medicine at the University of Washington, published an article last year showing that the cost has risen sharply and the development of drugs The high failure rate has caused many people to reassess the value of animal research.
The failure rate of drugs that enter clinical trials is extremely high. Studies have shown that the failure rate is as high as 90%, while other studies believe that the failure rate is close to 86%, which is mainly due to efficacy and safety issues
0 Comments for “Viscient Biosciences is using biological 3D printing technology for drug development”